You are using an outdated browser. Please upgrade your browser to improve your experience.

daclizumab

Ligand Summary
Description
An anti-TAC (INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT) humanized monoclonal antibody (immunoglobulin G1 disulfide with human-mouse monoclonal clone 1H4 light chain, dimer) that is used in the treatment of ACUTE RELAPSING MULTIPLE SCLEROSIS.
Synonyms & Links
ChEMBL: CHEMBL1201605
DrugCentral: 4953
LyCHI:  daclizumab


Target Activities